HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer
Clinical trial NCT04486651 · UNKNOWN
Trial details
- NCT number
- NCT04486651
- Sponsor
- Taizhou Hanzhong biomedical co. LTD
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2023-08-10
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.